These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, Toge T, Chayama K. Eur J Cancer; 2004 Aug; 40(12):1904-12. PubMed ID: 15288294 [Abstract] [Full Text] [Related]
24. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C. Clin Cancer Res; 2004 Dec 15; 10(24):8665-73. PubMed ID: 15623651 [Abstract] [Full Text] [Related]
30. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma]. Wu XA, Sun Y, Fan QX, Wang LX, Wang RL. Zhonghua Yi Xue Za Zhi; 2007 Jul 03; 87(25):1783-5. PubMed ID: 17919389 [Abstract] [Full Text] [Related]
31. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH. J Clin Pathol; 2008 May 03; 61(5):658-64. PubMed ID: 17908805 [Abstract] [Full Text] [Related]
34. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma. Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L. Laryngoscope; 2000 Aug 03; 110(8):1339-45. PubMed ID: 10942137 [Abstract] [Full Text] [Related]
35. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof]. Yu ZT, Zhao HF, Shang XB. Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2465-9. PubMed ID: 19080625 [Abstract] [Full Text] [Related]
36. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S, Bersiga A, Allevi G, Milani M, Aguggini S, Gandolfi V, Dogliotti L, Bottini A, Harris AL, Fox SB. Clin Cancer Res; 2006 Aug 01; 12(15):4562-8. PubMed ID: 16899602 [Abstract] [Full Text] [Related]
37. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL. Cancer Res; 2001 Apr 01; 61(7):2911-6. PubMed ID: 11306467 [Abstract] [Full Text] [Related]
38. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D. Lung Cancer; 2004 Aug 01; 45(2):181-8. PubMed ID: 15246189 [Abstract] [Full Text] [Related]
39. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Friesland S, Mellin H, Munck-Wikland E, Nilsson A, Lindholm J, Dalianis T, Lewensohn R. Anticancer Res; 2001 Aug 01; 21(1B):529-34. PubMed ID: 11299799 [Abstract] [Full Text] [Related]